Written by: marc

Tagworks to present at the European Antibody Congress in Basel

Tagworks will present the click-cleavable ADC technology at the European Antibody Congress, taking place on the 29th-31st October in Basel. http://www.terrapinn.com/conference/european-antibody-congress/index.stm
July 5, 2018

Published in Angewandte Chemie: ‘click-to-release’… more

Tagworks reports that the scope of its proprietary click-to-release reaction can be expanded from the cleavage of carbamates to ethers, potentially allowing more drug types to be released from their click-cleavable ADCs. https://doi.org/10.1002/anie.201800402
July 4, 2018

Tagworks publishes convincing results of cancer therapy in mice in Nature Communications

In mouse models of ovarian and aggressive colon cancer, Tagworks Pharmaceuticals has demonstrated the potent antitumour effect of the company's 'click-to-release' bioorthogonal chemistry approach. The results are published in the journal Nature Communications Raffaella Rossin, et al., Chemically triggered drug release from an antibody-drug conjugate leads to potent antitumour activity …
May 4, 2018

Tagworks@Antibody Engineering & Therapeutics Europe 2018, Amsterdam

Tagworks' CEO Marc Robillard is one of the speakers at Antibody Engineering & Therapeutics Europe 2018 in Amsterdam from 5-7 June. Marc will present the company's latest results on "Click chemistry-triggered drug release from a tumor-bound ADC" on Thursday 7 June. His lecture is part of a session on "Novel …
April 17, 2018

Tagworks@StartupDelta Summit, Arnhem, the Netherlands

Tagworks CEO Marc Robillard talks about entrepreneurship in the life sciences field and shares his experiences as co-founder of Tagworks Pharmaceuticals during the InnoBoot Session: Business meets Science at the StartupDelta Summit on Thursday April 19, 2018, in Arnhem, the Netherlands. More information on the event: https://startupdeltasummit.com/overdesummit/
April 5, 2018

Tagworks@19th ESRR in Groningen, the Netherlands

Tagworks CSO Raffaella Rossin presents the company's latest research achievements on 'In vivo click chemistry' at the 19th European Symposium on Radiopharmacy and Radiopharmaceuticals (ESRR) in Groningen, the Netherlands on Friday, April 6, 2018. More information: http://www.esrr.info/welcome-address/
April 5, 2018

Tagworks featured in BioCentury

Tagworks is featured in a BioCentury article on the state of the art and clinical prospects of in vivo click chemistry. https://www.biocentury.com/bc-innovations/tools-techniques/2017-06-15/new-use-click-chemistry-vivo-can-trigger-rapid-drug-?kwh=clear%3C%7C%3Eclears
June 27, 2017

Tagworks@EANM’17, Vienna

Tagworks CEO Marc Robillard will present at and co-chair the session on 'Bioorthogonal and Click Chemistry for Molecular Imaging' on Sunday October 21, 13:00-16:00, during the 30th Annual Conference of the European Association of Nuclear Medicine (EANM), October 21-25, 2017, Vienna, Austria. More information on EANM'17: http://eanm17.eanm.org
May 17, 2017

Tagworks@iSRS, Dresden

Tagworks' Research Manager Raffaella Rossin participates in the 22nd International Symposium on Radiopharmaceutical Sciences (iSRS) in Dresden, Germany, from May 14-19, 2017 More information on the conference: http://isrs2017.org
May 17, 2017

3rd Antibodies and Bio Therapeutics Congress, Las Vegas

8-9 November 2017, 3rd Antibodies and Bio Therapeutics Congress, Las Vegas
December 13, 2016

Curious about what we do? Get in touch!


T +31 85 800 8550

Tagworks Pharmaceuticals BV
Toernooiveld 1
6525 ED  Nijmegen
The Netherlands

Stay updated

© Tagworks Pharmaceuticals, 2023 | Terms of use | Design by Ape to Zebra